These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 61439)

  • 1. Fetal outcome in trial of antihypertensive treatment in pregnancy.
    Redman CW
    Lancet; 1976 Oct; 2(7989):753-6. PubMed ID: 61439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of antihypertensive efficacy and perinatal safety of labetalol and methyldopa in the treatment of hypertension in pregnancy: a randomized controlled trial.
    Plouin PF; Breart G; Maillard F; Papiernik E; Relier JP
    Br J Obstet Gynaecol; 1988 Sep; 95(9):868-76. PubMed ID: 3056503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevention of the maternal manifestations of pre-eclampsia by intensive antihypertensive treatment.
    Blake S; MacDonald D
    Br J Obstet Gynaecol; 1991 Mar; 98(3):244-8. PubMed ID: 2021561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methyldopa versus no drug treatment in the management of mild pre-eclampsia.
    Elhassan EM; Mirghani OA; Habour AB; Adam I
    East Afr Med J; 2002 Apr; 79(4):172-5. PubMed ID: 12625668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled trial of hypotensive agents in hypertension in pregnancy.
    Baker PA; Chadd MA; Humphreys DM; Leather HM
    Br Heart J; 1968 Nov; 30(6):871. PubMed ID: 4888042
    [No Abstract]   [Full Text] [Related]  

  • 6. Antihypertensive drugs in pregnancy.
    Naden RP; Redman CW
    Clin Perinatol; 1985 Oct; 12(3):521-38. PubMed ID: 2865023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hypertension in pregnancy with methyldopa: a randomized double blind study.
    Weitz C; Khouzami V; Maxwell K; Johnson JW
    Int J Gynaecol Obstet; 1987 Feb; 25(1):35-40. PubMed ID: 2883043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of Hypertension In Pregnancy Study randomised controlled trial-are the results dependent on the choice of labetalol or methyldopa?
    Magee LA; ; von Dadelszen P; Singer J; Lee T; Rey E; Ross S; Asztalos E; Murphy KE; Menzies J; Sanchez J; Gafni A; Gruslin A; Helewa M; Hutton E; Koren G; Lee SK; Logan AG; Ganzevoort JW; Welch R; Thornton JG; Moutquin JM
    BJOG; 2016 Jun; 123(7):1135-41. PubMed ID: 26259808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infant growth and development after treatment of maternal hypertension.
    Myerscough PR
    Lancet; 1980 Apr; 1(8173):883. PubMed ID: 6103245
    [No Abstract]   [Full Text] [Related]  

  • 10. Antihypertensive treatment in pregnancy: analysis of different responses to oxprenolol and methyldopa.
    Gallery ED; Ross MR; Gyory AZ
    Br Med J (Clin Res Ed); 1985 Aug; 291(6495):563-6. PubMed ID: 3929874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised comparison of methyldopa and oxprenolol for treatment of hypertension in pregnancy.
    Gallery ED; Saunders DM; Hunyor SN; Györy AZ
    Br Med J; 1979 Jun; 1(6178):1591-4. PubMed ID: 466138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of hypertension in pregnancy with methyldopa: blood pressure control and side effects.
    Redman CW; Beilin LJ; Bonnar J
    Br J Obstet Gynaecol; 1977 Jun; 84(6):419-26. PubMed ID: 329859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive treatment and pregnancy outcome in patients with mild chronic hypertension.
    Arias F; Zamora J
    Obstet Gynecol; 1979 Apr; 53(4):489-94. PubMed ID: 440653
    [No Abstract]   [Full Text] [Related]  

  • 14. Pregnancy Outcome After First Trimester Use of Methyldopa: A Prospective Cohort Study.
    Hoeltzenbein M; Beck E; Fietz AK; Wernicke J; Zinke S; Kayser A; Padberg S; Weber-Schoendorfer C; Meister R; Schaefer C
    Hypertension; 2017 Jul; 70(1):201-208. PubMed ID: 28533329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Maternal effects and perinatal safety of labetalol in the treatment of hypertension in pregnancy. Comparison with methyldopa in a randomized cooperative trial].
    Plouin PF; Bréart G; Maillard F; Papiernik E; Relier JP
    Arch Mal Coeur Vaiss; 1987 Jun; 80(6):952-5. PubMed ID: 3116996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonidine hydrochloride--a safe and effective antihypertensive agent in pregnancy.
    Horvath JS; Phippard A; Korda A; Henderson-Smart DJ; Child A; Tiller DJ
    Obstet Gynecol; 1985 Nov; 66(5):634-8. PubMed ID: 3903581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in using beta-blockers and methyldopa for hypertensive disorders during pregnancy in a Canadian population.
    Xie RH; Guo Y; Krewski D; Mattison D; Nerenberg K; Walker MC; Wen SW
    Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):281-5. PubMed ID: 24139131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension in pregnancy. A study of 142 women presenting before 32 weeks' gestation.
    Horvath JS; Korda A; Child A; Henderson-Smart D; Phippard A; Duggin GG; Hall BM; Tiller DJ
    Med J Aust; 1985 Jul; 143(1):19-21. PubMed ID: 4010599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infant growth and development following treatment of maternal hypertension.
    Ounsted M; Moar V; Redman CW
    Lancet; 1980 Mar; 1(8170):705. PubMed ID: 6103107
    [No Abstract]   [Full Text] [Related]  

  • 20. [Methyldopa in therapy of hypertension in pregnant women].
    Seremak-Mrozikiewicz A; Drews K
    Ginekol Pol; 2004 Feb; 75(2):160-5. PubMed ID: 15108591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.